LITTLE KNOWN FACTS ABOUT CONOLIDINE.

These final results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two assist the principle of targeting ACKR3 as a singular technique to modulate the opioid technique, which could open up new therapeutic avenues for opioid-relevant Conditions.The positioning is protected.